Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)
Egypt
· Delayed Price · Currency is EGP 4.330
-0.050 (-1.14%)
At close: Aug 14, 2025
EGX:RMDA Revenue
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) had revenue of 963.33M EGP in the quarter ending June 30, 2025, with 70.53% growth. This brings the company's revenue in the last twelve months to 3.58B, up 70.22% year-over-year. In the year 2024, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) had annual revenue of 2.77B with 44.03% growth.
Revenue (ttm)
3.58B
Revenue Growth
+70.22%
P/S Ratio
1.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
6.54B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.77B | 846.34M | 44.03% |
| Dec 31, 2023 | 1.92B | 438.40M | 29.54% |
| Dec 31, 2022 | 1.48B | 237.52M | 19.06% |
| Dec 31, 2021 | 1.25B | 286.27M | 29.81% |
| Dec 31, 2020 | 960.17M | 66.20M | 7.41% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Commercial International Bank Egypt (CIB) S.A.E. | 111.86B |
| El Sewedy Electric Company | 253.16B |
| Talaat Moustafa Group Holding | 50.04B |
| Eastern Company S.A.E | 34.08B |
| Misr Fertilizer Production Company | 23.05B |
| Telecom Egypt Company | 89.35B |
| Egypt Aluminum | 42.42B |
| Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.) | 22.92B |